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Clinical Results
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Reuben K. Rivera, OD, MS,1 Meng C. Lin, OD,1 Timothy L. Sanders, OD,1
Nancy A. McNamara, OD, PhD,1 Judy S. Chan, OD, MS1
Objective: To describe the principal clinical outcomes associated with 12 months use of rigid gas-perme-
able (RGP) extended wear contact lenses and address two primary study questions: (1) does extended wear (EW)
of high oxygen transmissibility (Dk/t) RGP lenses reduce the incidence of ocular complications, and (2) does the
wearing of high-Dk/t lenses reduce the rate of failure to maintain 6-night RGPEW over 12 months?
Design: A randomized, concurrently controlled clinical trial.
Intervention: Subjects who adapted to EW with high Dk (oxygen permeability) RGP lenses were randomized
to either high Dk or medium-Dk RGP lenses for 12 months of 6-night EW.
Main Outcome Measures: Contact lens-associated keratopathies (CLAK), changes in refractive error and
corneal curvature, and survival in EW.
Results: Two hundred one subjects were randomized to medium or high-Dk lenses for 12 months of EW.
Sixty-two percent of the subjects in each group completed 12 months of EW; however, the probability of failure
was significantly greater for the medium-Dk group. Although the risk of complications was similar for the two
groups, the number of CLAK events that led to termination were 16 versus 5 for the medium-Dk and high-Dk
groups, respectively. This suggests that the type of adverse response or the inability to reverse an adverse event
was different for the group being exposed to the lower oxygen dose.
Conclusions: The level of oxygen available to the cornea has a significant impact on maintaining
successful RGP extended contact lens wear, but not on the initial onset of CLAK. The number of clinical
events leading to termination was substantially higher for the medium Dk group, which suggests that corneal
hypoxia is an important factor in the development of CLAK. Although overnight contact lens wear should be
recommended with caution and carefully monitored for early detection of ocular complications, it appears
that high-Dk RGP lenses can be a safe and effective treatment for correction of refractive error for most
individuals who can adapt to EW. Ophthalmology 2001;108:1389 –1399 © 2001 by the American Academy
of Ophthalmology.
The Berkeley Contact Lens Extended Wear Study
(CLEWS) was a randomized, concurrently controlled
clinical trial designed to examine the effects of corneal
hypoxia on ocular complications arising from the ex-
tended wear of rigid gas-permeable (RGP) contact lenses
of either medium or high oxygen permeability (Dk). In
part I of this report, we described the background, design,
and implementation of CLEWS. In that article, we
showed that the distributions of lens oxygen transmissi-
bility (Dk/t) in the lenses assigned to the two study
groups were completely disjoint (Fusaro RE, Polse KA,
Graham AD, The Berkeley Contact Lens Extended Wear
Study. Part I: Study Design and Conduct), confirming
that subjects randomized to the medium-Dk lens group
were subject to a greater degree of hypoxia. Providing
different oxygen levels to each group permitted us to
explore the association between hypoxic dose and certain
clinical outcomes associated with 12 months of rigid
gas-permeable extended wear (RGPEW) by addressing
two primary study questions:
1. Does extended wear of high-Dk RGP lenses, rather
than medium-Dk RGP lenses, reduce the incidence of
ocular complications?
2. Does the wearing of high-Dk RGP lenses, rather than
medium-Dk RGP lenses, reduce the rate of failure to
maintain 6-night RGPEW?
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Materials and Methods
In this section, we briefly review the CLEWS design, explain our
strategy for quantifying various types of ocular complications for
analysis, and present the statistical methodology we used in ana-
lyzing the CLEWS clinical trial data. The reader is encouraged to
refer to part I for a more comprehensive treatment of the issues
relevant to assessing the integrity of the data and to interpreting
and generalizing the results presented in this companion article.
Overview of the Berkeley Contact Lens Extended
Wear Study Design
The Berkeley CLEWS was a randomized, concurrently controlled
clinical trial designed to evaluate the hypothesis that ocular mor-
bidity in RGPEW is associated with the level of corneal hypoxia
induced by the lenses. The trial was structured with three main
stages. In stage 1, prospective subjects were oriented to the goals
and procedures of the study and then examined to determine
eligibility. In stage 2, subjects were adapted to contact lens wear,
beginning with daily wear and progressing to full-time (i.e., 6
nights per week) extended wear (EW). Those who were able to
achieve full-time EW then proceeded to stage 3 and were ran-
domly assigned either medium- or high-Dk lenses for 12 months of
full-time EW. Stage 3 subjects attended quarterly visits, during
which optometrists conducted detailed interviews, slit-lamp exam-
inations, visual acuity assessments, and refractive error (RE) and
corneal curvature (K) readings. Results of stage 1 and stage 2
recruitment and retention efforts and baseline subject data are
presented in part I. The clinical outcomes for the two randomized
subject groups are compared in this article.
Contact Lens-associated Keratopathy
To compare the incidence of ocular complications between the two
lens groups, it was necessary to define contact lens-associated
keratopathy (CLAK). We asked six experienced contact lens prac-
titioners who were not associated with CLEWS and who were
unaware of any CLEWS interim results to complete a survey
detailing the severity of complications that they believed would
typically require intervention (e.g., changing lens parameters, pre-
scribing medications, temporarily discontinuing lens wear to allow
the complication to subside, completely terminating lens wear).
The survey respondents were presented with 17 possible keratopa-
thies and asked to indicate for each condition the minimum grade
of severity (0 5 none, 1 5 mild, 2 5 moderate, 3 5 severe) that
they would consider an adverse event requiring clinician interven-
tion. Each clinician was also asked to indicate the number of
events of lesser severity that, if observed concurrently, would
require intervention. Finally, they were asked to indicate the di-
opters of refractive error (RE) and corneal curvature (K) change
from prefitting measurements that they would characterize as an
adverse response requiring intervention. The survey results led to
the CLAK definitions reported in Table 1.
Our goal was to quantify CLAK in a manner that would reflect
the consensus opinion of the outside clinicians and be meaningful
in practice (i.e., as adverse responses severe enough to require
clinician intervention). Using the survey results, we constructed
four increasingly inclusive definitions of CLAK and repeated our
analyses using each of these four definitions. With this approach,
we were able to assess the ocular response to hypoxic dose while
allowing for more or less restrictive definitions of CLAK, thereby
facilitating comparison with other studies that may use different
criteria in reporting incidences of lens-related complications. Us-
ing our first definition of CLAK (type 1), we examined the effects
of hypoxic dose on the occurrence of any keratopathy detected by
slit-lamp examination in either eye, whose severity equaled or
exceeded the average of the six survey responses rounded to the
nearest severity grade. Type 1 CLAK also included lens adherence
that required changes to the lens parameters. Lens binding that was
less frequent or was alleviated by the use of solutions, cleaning or
polishing the lens, or further training of the subject in lens care and
handling procedures was not considered a type 1 CLAK. Lens
adherence was not included in the original survey because it was
thought that individuals subject to persistent lens adherence would
not be able to complete the EW adaptation period, and therefore
adherence would not occur in our randomized subjects. However,
a data quality review revealed that several randomized subjects did
experience persistent lens binding, thus prompting a manual search
of the entire bank of patient records to ascertain all such cases of
adherence. Randomization assignment was not revealed during the
search, and at the time the decision was made to include lens
adherence as a type 1 CLAK, it was not known whether the two Dk
groups differed in adherence rate.
We then expanded our definition of CLAK (type 2) to include
type 1 CLAK and changes in K or RE from baseline in either eye
Table 1. Definitions of Contact Lens-associated Keratopathy
Keratopathy or
Adverse Event
Minimum Value
Defined as Contact
Lens-associated
Keratopathy
Bulbar conjuctiva
Injection 2
Staining
Superior 1
Inferior 2
Nasal 2
Temporal 2
Palpebral conjunctival injection
Superior tarsus 2
Inferior tarsus 2
Hypertrophy
Superior tarsus 2
Inferior tarsus 2
Corneal staining
Central 1
Peripheral 2
Corneal infiltrates
Central 1
Peripheral 1
Microcysts 2
Striae 2
Polymegethism 2
Tear debris 2
Lens adherence 3 times weekly, persistent
Change in corneal curvature
Horizontal meridian 0.88
Vertical meridian 0.83
Change in refractive error
Sphere 0.88
Cylinder 0.92
Simultaneous subclinical slit-lamp
findings (n)
3
Discomfort and related symptoms 2
Type 1 contact lens-associated keratopathy includes slit-lamp findings and
lens adherence; type 2 includes both type 1 responses and changes in
corneal curvature or refractive error; type 3 includes both type 2 and
multiple, simultaneous subclinical findings; type 4 includes both type 3
and subjective symptoms related to discomfort. Severity grading: 0 5
none, 1 5 mild, 2 5 moderate, 3 5 severe.
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that exceeded the mean diopters of change indicated by the survey
respondents. Our third definition of CLAK (type 3) included three
or more simultaneous “subclinical keratopathies” (i.e., observed at
the slit lamp, but less severe than the grades qualifying as type 1)
in either eye, in addition to type 2 CLAK. Finally, we repeated our
analyses using a fourth definition (type 4) that included type 3
CLAK or moderate to severe discomfort, burning, itching, or pain
at a regularly scheduled clinical assessment, or these symptoms to
such a degree that an unscheduled visit was needed.
Statistical Methods
An attractively simple way to summarize the failure experience of
subjects at risk for an adverse event is by the simple proportion of
subjects who fail over the course of the study. This approach is
inappropriate, however, for several reasons. First, it is inefficient in
that it fails to use data concerning the specific times at which
failures occurred and, rather, treats all failures within the study
period as the same. Second, this approach ignores the fact that only
incomplete, or censored, information may be available for some
subjects. Subjects may provide partial, right-censored data because
they elected to discontinue study participation or were terminated
from the study by the clinician for reasons unrelated to study lens
wear, such as time commitment, general disinterest, or noncom-
pliance with the study protocol. An unknown number of these
subjects may have suffered lens-related adverse events had they
been available for the entire 12-month observation period. Subjects
were failed for noncompliance by the clinician if they were unable
or unwilling to attend the required laboratory visits consistently, if
there were frequent lens care or handling problems as a result of
failure to follow instructions or if subjects were inconsistent in
maintaining their 6-night EW schedule. For subjects who missed
scheduled visits and did not contact the laboratory, the Study
Coordinator followed a standard procedure for attempting to con-
tact the subject before completing a termination form. Adverse
events were defined as initial onset of a CLAK condition (for study
question 1) and termination from the study as a result of a type 4
CLAK condition (for study question 2).
To account for censoring, we used the product-limit (Kaplan-
Meier) approach1 to estimate the Dk group-specific survival
curves, which characterize the probabilities of successful EW or
freedom from complications over time. The homogeneity of the
survival curves between Dk groups was assessed using a log-rank
test.1 Estimates of the relative risk of complications or RGPEW
failure associated with hypoxic dose were obtained by fitting Cox
proportional hazards models.1 We used the SAS (SAS Institute,
Inc., Cary, NC) procedures LIFETEST and PHREG to implement
these survival analytic techniques.2
It has been suggested that overnight lens wear, particularly with
lower-Dk materials, may alter corneal topography.3,4 We therefore
attempted to ascertain whether K or RE in our RGPEW subjects
differed between Dk groups or changed over time in either group.
We used the SAS procedure MIXED to implement a mixed effects
analysis of variance approach to comparing changes from baseline
in K (horizontal and vertical meridians) and RE (sphere and
cylinder components) in the two Dk groups.2 We modeled the
change from baseline in each of these outcomes with fixed effects
for Dk group and visit (3, 6, 9, and 12 months) within each group
and a compound symmetric covariance structure to account for the
correlations among repeated measurements on the two eyes of
each subject across visits. This structure assumes a common co-
variance among all measurements on a single subject.
Results
Overview
This section is divided into four parts. In the first part, we describe
subject participation rates by visit along with the reasons subjects
dropped out or were terminated from the study. The second section
presents our basic clinical observations, including group trends in
RE and K, the specific types of keratopathy encountered, and
detailed descriptions of those subjects in each group who had to
discontinue overnight lens wear completely because of CLAK.
The third section addresses the first of our primary CLEWS
questions by comparing the probabilities of the two types of lens
wearers remaining free from complications through time and by
estimating the relative risk of complications associated with hy-
poxic dose. Finally, in the fourth section, we address the second of
our two primary CLEWS questions by comparing the estimated
survival probability curves between groups and estimating the
relative risk of failure to maintain EW associated with hypoxic
dose.
Subject Retention, Termination, and Loss to
Follow-up
Of 2218 subjects who attended an orientation meeting, 545 sub-
jects were deemed eligible and were willing to participate in
CLEWS. These subjects were fit with high-Dk lenses for daily
wear adaptation. Of the 344 subjects who proceeded from daily
wear to EW adaptation, 201 subjects adapted to EW and were
randomized to either medium-Dk (n 5 103) or high-Dk (n 5 98)
RGP lenses for 12 months of full-time EW. Our stratified block
randomization scheme, detailed in part I of this report, ensured that
approximately the same number of subjects were assigned to each
lens group at any given point during the study and that ages and
genders were balanced between the two groups.
Table 2 shows the number of subjects examined at each quar-
terly visit in the two groups and the number failing to attend each
scheduled assessment. Of the 103 medium-Dk wearers, 24 subjects
did not complete the first quarterly visit, and data were collected on
the remaining 79 subjects. Of these 24 subjects who did not
participate in the 3-month examination, 3 returned for subsequent
visits, whereas 21 were either lost to follow-up or failed as a result
of complications before the first quarterly visit. The high-Dk group
showed a similar pattern; 19 of the 98 randomized subjects failed
to complete the first visit, leaving 79 available for 3-month obser-
vations. After these relatively large losses of subjects early in the
course of follow-up, the number of subjects failing to complete
subsequent visits declined. At final count, 64 subjects (62.1%) in
the medium-Dk group and 61 subjects (62.2%) in the high-Dk
group were able to complete the entire 12 months of RGPEW
successfully.
During the postrandomization phase, some subjects required
one or more appointments in addition to the quarterly assessments.
These unscheduled visits were either initiated by the patient be-
cause of a lens-related problem or an ocular symptom or by the
clinician at the time of a regularly scheduled clinical assessment as
a result of a slit-lamp finding requiring monitoring or follow-up
care. The reasons reported for unscheduled visits are shown in
Table 3. Over the postrandomization period, there were a total of
91 unscheduled visits from 53 subjects in the medium-Dk group
and 77 visits from 42 subjects in the high-Dk group. Replacement
of lost lenses was the most common reason for unscheduled visits,
although there were a substantial number of visits as a result of
onset of adverse symptoms, primarily red eye and foreign body
sensation in both groups, discomfort and blurred vision in the
medium-Dk group, and pain in the high-Dk group. The most
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common slit-lamp findings at the unscheduled visits were corneal
and bulbar conjunctival staining, with few or no occurrences of
corneal striae, hypertrophy, infiltrates, microcysts, injection, or
polymegethism.
The reasons for termination or drop-out before 12 months in the
two study groups are provided in Figure 1. Most failures and
drop-outs in both groups occurred within 3 months after random-
ization, although the reasons for failure differ between the groups.
In the high-Dk group, most subjects unavailable for the first
quarterly visit (n 5 18) either elected to drop out for reasons
unrelated to contact lens wear or were terminated for noncompli-
ance, whereas only two subjects failed for lens-related adverse
responses. In contrast, in the medium-Dk group, the reasons for
failures before the first quarterly visit were nearly evenly divided
between those unrelated to lens wear (n 5 11) and lens-related
adverse responses (n 5 10). Over the remaining visits, the medi-
um-Dk group continued to demonstrate comparable numbers of
failures for lens-related complications (n 5 7) and reasons unre-
lated to contact lens wear (n 5 8). The high-Dk group also
continued its pattern of reasons for failure, with far more unrelated
to lens wear (n 5 14) than lens-related adverse responses (n 5 2).
Clinical Observations
In this section, we present further observational data that do not, by
themselves, directly address the two primary CLEWS research
questions, but nevertheless are of clinical interest. We first report
on changes observed in K and RE, then describe the specific types
of keratopathy encountered in the two lens groups and present the
detailed diagnoses of the 21 subjects failing for lens-related ocular
complications. In the two sections that follow this clinically ori-
ented presentation, we apply the appropriate survival analytic
techniques to these data to address directly the two primary ques-
tions for which CLEWS was designed.
Changes in Refractive Error and Corneal Curvature. To
determine whether overnight wear of medium- or high-Dk RGP
lenses is associated with changes in K or RE over time, manifest
refraction and keratometry readings were performed at the baseline
subject evaluation and at each of the quarterly clinical assessments.
For both Dk groups, average changes in the spherical refractive
component from baseline measurements were small and in the
direction of reduced myopia (ranging from 0.12–0.20 diopters [D]
at the different visits), and for the cylinder there were small
reductions in the astigmatic component (ranging from 0.11–0.15
D). Keratometry for both Dk groups showed modest decreases in
power in both the vertical and horizontal meridians (ranging from
0.46–0.51 D). There were no significant Dk group or visit effects
on any of these measures within the two Dk groups. In Figure 2,
the change from baseline in refractive sphere, using the average of
each subject’s two eyes, is shown stratified by visit for the medi-
um- and high-Dk groups, illustrating the lack of clinically impor-
tant changes in corneal topography found in both RE and kera-
tometry measurements. From these results, we concluded that
overnight wear of RGP lenses does not significantly affect corneal
topography, nor does the oxygen permeability of the lens.
Observations of Lens-related Complications. Table 4 shows
the overall number of cases of CLAK observed during the CLEWS
clinical trial for each of our definitions, under all four of which a
slightly larger number of subjects had complications in the medi-
um-Dk group than in the high-Dk group. Of potential clinical
interest are the specific types of slit-lamp findings from up to 1
year of observation of more than 200 RGPEW patients, which are
presented in Table 5. By far the most commonly observed kera-
topathy in both groups was corneal staining, which occurred more
often in the central cornea than in the periphery, followed by
redness and staining of the conjunctiva (20 cases in the medi-
um-Dk group versus 10 cases in the high-Dk group over all visits).
There were 3 cases of corneal infiltrates and 13 cases of moderate-
to-severe striae in the medium-Dk group, compared with the
high-Dk group in which no infiltrative events and 2 cases of
CLAK-grade striae occurred. Lens adherence that required chang-
ing lens parameters occurred in subjects in each group. There were
Table 2. Contact Lens-associated Keratopathy CLEWS Subject Participation
Follow-up Visit (mos)
Medium Oxygen Permeability Group
(n 5 103)
High Oxygen Permeability Group
(n 5 98)
3 6 9 12 3 6 9 12
Completed visit 79 73 66 64 79 67 64 61
Did not complete visit 21 7 7 2 18 11 4 2
Cumulative 21 28 35 37 18 29 33 35
Missed visit but returned 3 2 2 2 1 2 1 2
Shown are the numbers of contact lens-associated keratopathy subjects in each randomized study group who completed or failed to complete each
scheduled follow-up visit. Occasionally, subjects would miss a scheduled visit without discontinuing study participation (e.g., for an extended vacation)
and return to the study for subsequent visits.
Table 3. Reasons for Unscheduled Visits for Initial Onset of
Symptoms (Follow-up Examinations for Previously Identified
Conditions Not Included in This Summary)
Medium Oxygen
Permeability
Group
High Oxygen
Permeability
Group
No. subjects requiring unscheduled
visits
53 42
Total number of unscheduled visits
by these subjects
91 77
No. subjects reporting reason for
visit (may be .1 reason, .1
visit per subject, or both)
Lost lens 20 17
Red eye 16 12
Pain 10 16
Discomfort 16 9
Foreign body sensation 14 11
Blurred vision 12 8
Tearing 10 6
Drying 10 2
Burning 4 8
Itching 5 5
Photophobia 6 4
Cracked/broken lens 2 5
Discharge 4 3
Lens handling problem 1 1
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few or no cases of microcysts or polymegethism in either group. It
is also interesting that in this study of RGPEW, we did not observe
any cases of microbial keratitis, neovascularization, or acute red
eye, which often occur in soft contact lens extended wear
(SCLEW).5–7
Figure 3 shows the days from randomization to complete
discontinuation of EW for the 21 subjects who were terminated
from the study because of type 4 CLAK, along with the specific
causes of failure. In total, 16 subjects in the medium-Dk group
were terminated before 12 months of follow-up because of kera-
topathy or discomfort, whereas only high-Dk subjects failed for
reasons directly related to lens wear. Of the 16 medium-Dk group
terminations, 5 subjects failed for persistent lens adherence (i.e.,
after having successfully adapted to EW in stage 2 while wearing
the high-Dk adaptation lenses), whereas 1 of the 5 failures in the
high-Dk group was the result of adherence. All five cases of
persistent lens adherence in the medium-Dk group eventually
required complete discontinuation of EW, whereas four of the five
adherence cases in the high-Dk group were resolved successfully.
Although these clinical observations are suggestive of a greater
risk of some lens-related complications, EW failure, or both in the
medium-Dk group, censoring resulting from non-CL related fac-
tors makes survival analytic methods necessary for unbiased com-
parisons of the two Dk groups.
Association of Hypoxic Dose with Ocular
Complications
In this section, we present the survival analyses for time to initial
onset of CLAK for each of the four definitions of CLAK. The
number of elapsed days was calculated from the date of dispensing
of the randomized study lenses to the date the clinician first
observed a CLAK event, which could have occurred at a regularly
scheduled clinical assessment or an unscheduled visit; subjects
who never exhibited such complications are right-censored at their
last observation time 12 months or fewer from randomization. We
analyzed the initial onset of CLAK for each subject rather than
multiple CLAK events because of the difficulty in distinguishing
unique events from recurrence of previously treated conditions and
because attempts to ameliorate the first observed keratopathy often
included disruption of the EW schedule for varying periods of
time. Furthermore, termination from the study because of a CLAK
event censors such subjects with respect to possible subsequent
events, but is not independent of the risk of such subsequent
CLAK events as is required for the use of standard survival
analytic techniques.
Figure 4 depicts the survival curves characterizing the proba-
bility of remaining free from complications under the two different
levels of hypoxia induced by the study lenses. The height of a
Figure 1. After randomization to the medium or high oxygen permeability (DK) study group, subjects could be dropped from the study by the clinician
as a result of lens-related complications that could not be resolved, or for reasons unrelated to wearing the study lenses such as noncompliance with the
study protocol. Subjects themselves could elect to discontinue participation for lens-related discomfort if the clinician was unable to resolve the symptom,
or for various other reasons unrelated to lens wear (e.g., moving out of the area).
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survival curve at any given point represents the estimated proba-
bility that a subject will remain free of complications until at least
that point. Under all four definitions of CLAK, the survival curves
for the two Dk groups are virtually identical. The noticeable drop
in the survival curves after 3 months in part may be the result of
our examination schedule: subjects were generally not seen for 3
months after the dispensing of the randomized study lenses and
may have experienced CLAK early on that was not detected until
the first regularly scheduled quarterly follow-up visit; after that
time, more opportunities may have been available to detect CLAK
onset, because the clinician could note adverse symptoms at the
3-month visit and request unscheduled visits or encourage the
Figure 2. Shown is the change from baseline in refractive sphere in the medium and high oxygen permeability (DK) groups at each visit. The bars
represent the least squares means and 95% confidence intervals. There was no significant difference between DK groups in refractive sphere change from
baseline (prefitting) measurements. There was no significant change across visits for either group. D 5 diopters.
Table 4. Cases of Contact Lens-associated Keratopathy in the Two Lens Oxygen Permeability Groups
Follow-up Visit (mos)
Medium Oxygen Permeability Group (n 5 103) High Oxygen Permeability Group (n 5 98)
3 6 9 12 Total 3 6 9 12 Total
Number of active subjects 79 73 66 64 79 67 64 61
CLAK type 1 (slit-lamp
findings only)
11 24 16 15 66 9 20 18 9 56
CLAK type 2 (including
change in corneal
curvature, refractive
error)
11 45 19 7 82 12 43 14 7 76
CLAK type 3 (including
subclinical findings)
12 48 18 7 85 13 47 13 5 78
CLAK type 4 (including
discomfort)
15 51 16 7 89 16 48 12 5 81
CLAK 5 contact lens-associated keratopathy.
Shown are the number of subjects presenting with CLAK in either eye for the first time during their course of follow-up. CLAK discovered at an
unscheduled visit is included in the count for the nominal follow-up visit closest to date of initial detection.
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subject to call the laboratory before the next scheduled visit to
monitor developments. Table 6 shows the log-rank tests for ho-
mogeneity of survival curves. The P values represent the proba-
bility of observing survival curves at least as discrepant as we
observed if there truly were no difference in the survival rates for
the underlying populations. The relatively large P values confirm
that there are no statistically significant differences between Dk
groups in the probability of remaining free from ocular complica-
tions, regardless of the definition of CLAK used.
Also shown in Table 6 are estimates of the relative hazard of
experiencing a CLAK with approximate 95% confidence limits.
The relative hazard is a ratio of the group-specific hazard rates
obtained from a Cox proportional hazards model. A relative hazard
of 1 indicates that the risk of experiencing a CLAK is the same in
the two Dk groups, whereas a relative hazard more than 1 reflects
an increased risk of CLAK onset in the medium-Dk group. Table
6 shows that if we use Dk group (medium or high) as a predictor
of type 1 CLAK, we obtain a relative hazard of 1.10 (0.77, 1.57),
Table 5. Slit-lamp Findings by Visit
Follow-up Visit (mos)
Medium Oxygen Permeability Group (n 5 103) High Oxygen Permeability Group (n 5 98)
3 6 9 12 3 6 9 12
No. of active subjects 79 73 66 64 79 67 64 61
Bulbar conjunctiva
Injection 3 2 0 0 0 3 1 0
Staining 8 5 2 5 2 1 2 5
Palpebral conjunctival injection 2 0 0 0 1 1 0 1
Hypertrophy 1 2 0 1 0 0 1 1
Corneal staining
Central 23 17 15 14 22 21 13 11
Peripheral 14 9 4 4 7 6 5 4
Corneal infiltrates 1 2 0 0 0 0 0 0
Microcysts 0 0 0 0 0 0 0 1
Striae 2 3 3 5 0 1 1 0
Polymegethism 0 0 0 1 0 0 0 0
Tear debris 1 0 0 0 1 0 0 1
Lens adherence 3 2 0 0 5 0 0 0
Shown are the number of contact lens-associated keratopathy grade cases of several possible keratopathies, stratified by visit. Subjects may have had more
than one keratopathy at presentation. Actual visit dates varied from the nominal quarterly visits shown, and adverse responses observed at unscheduled
or emergency visits are included in the count for the nominal visit nearest the date of initial detection.
Figure 3. Sixteen subjects in the medium oxygen permeability (DK) group and 5 subjects in the high DK group failed for lens-related adverse responses.
Shown for all 21 subjects are the number of days after beginning wear of the randomized study lenses that they were able to continue lens wear and the
specific findings that led to termination of wear. SPK 5 superficial punctate keratitis.
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indicating that subjects in the medium-Dk group do not have
significantly elevated risk of experiencing type 1 CLAK compared
with the high-Dk group. The upper confidence bound shows that
we have sufficient statistical power to rule out (with 95% confi-
dence) anything but a minor elevation in the risk of a type 1 CLAK
associated with medium-Dk EW.
We also performed our survival analyses using the lens-specific
Dk/t as a continuous predictor in addition to the Dk-group analy-
ses. The difference in mean Dk/t between the two study groups
was approximately 25 units. Using this as an example, we esti-
mated a corresponding increased risk of 1.02 (0.76, 1.39) associ-
ated with a 25 unit decrease in Dk/t. For the other definitions of
Figure 4. Survival curves showing the estimated probability of surviving free of contact lens-associated keratopathy (CLAK) are shown for four possible
definitions of CLAK. Type 1 CLAK consists of slit-lamp findings and lens adherence; type 2 CLAK consists of type 1 CLAK findings or changes in
refractive error or corneal curvature; type 3 CLAK consists of type 2 responses or multiple, simultaneous subclinical slit-lamp findings; type 4 CLAK
consists of type 3 findings or subjective symptoms related to discomfort. Under all four definitions, there was no significant difference in probability of
survival free of CLAK. DK 5 oxygen permeability.
Table 6. Survival in Rigid Gas-permeable Extended Wear Lenses to Onset of Contact Lens-associated Keratopathy
Adverse Response Type Type 1 Type 2 Type 3 Type 4
Test of survival curves (P value)
Medium vs. high oxygen permeability group 0.60 0.57 0.56 0.75
Estimated hazard ratios
Medium vs. high oxygen permeability group 1.10 0.91 0.91 0.95
(Approximate 95% confidence interval) (0.77, 1.57) (0.67, 1.25) (0.67, 1.24) (0.70, 1.29)
Oxygen transmissibility (25 units difference) 1.02 0.89 0.90 0.94
(Approximate 95% confidence interval) (0.76, 1.39) (0.68, 1.16) (0.69, 1.17) (0.73, 1.21)
Shown are the log-rank tests of homogeneity of survival curves in the two oxygen permeability lens groups, and the estimated hazard ratios and
approximate 95% confidence intervals derived from Cox proportional hazards models.
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CLAK, relative hazards ranged from 0.89 (0.68, 1.16) to 0.94
(0.73, 1.21), which are consistent with the hypothesis that there is
no increased risk of CLAK onset (by any of our definitions) with
increased hypoxic dose.
Association of Hypoxic Dose with Failure to
Maintain Rigid Gas-Permeable Extended Wear
Although the above analysis shows that hypoxic dose is not
associated with development of ocular complications, this does not
preclude the possibility that oxygen dose is associated with the
ability to maintain 6-night RGPEW successfully, because 16 sub-
jects completely discontinued EW due to adverse ocular response
in the medium-Dk group, compared with only five in the high-Dk
group.
Figure 5 (first panel) shows the survival curves for all subjects
in the medium-Dk and high-Dk groups, where the time-to-outcome
was defined as the time from randomization until termination from
the study because of contact lens-associated adverse responses
including slit-lamp findings or unresolvable lens adherence or
discomfort. Subjects who exited the study before 12 months of EW
because of time commitment, general disinterest, noncompliance
with the study protocol, or other reasons unrelated to contact lens
wear provided data censored at exit time. The survival curve for
the high-Dk group dropped gradually over time, whereas the
medium-Dk curve dropped more quickly, reflecting an increased
risk of failure. Table 7 (first column) shows the log-rank test of
homogeneity of these survival curves, which reveals that the
increased probability of survival in the high-Dk group was statis-
tically significant (P 5 0.02). To illustrate the decreased proba-
bility of survival in the medium-Dk group, we used the survival
curves to estimate the probabilities and 95% confidence bounds for
survival beyond 9 months (column 1 of Table 8). The high-Dk
group enjoys approximately a 13% greater probability of survival
beyond 9 months compared with the medium-Dk group. From a
Cox proportional hazards model (Table 7, first column), we esti-
mated a relative hazard of 3.08 (1.13, 8.41), indicating that the
Figure 5. Survival curves showing the estimated probability of surviving in extended wear (EW) are shown for all Berkeley Contact Lens Extended Wear
Study subjects and for those with contact lens-associated keratopathy (CLAK). In the first panel are survival curves for all randomized subjects, which
show that the high oxygen permeability (DK) group enjoys a significantly greater probability of survival in EW; in the second panel are survival curves
from time of initial onset for subjects in whom any CLAK (type 4) developed, showing that the recovery of subjects in whom CLAK develops is impeded
in the medium DK group, which may explain the reduced medium DK EW survival rate despite CLAK onset rates comparable with the high DK group.
Table 7. Survival in Rigid Gas Permeable Extended
Wear Lenses
All
Subjects
Subjects with
any Contact
Lens-associated
Keratopathy
(Type 4)
Test of survival curves (P value)
Med. vs. high oxygen permeability group 0.02 0.01
Estimated hazard ratios
Med. vs. high oxygen permeability group 3.08 3.26
(Approximate 95% confidence interval) (1.13, 8.41) (1.19, 8.92)
Oxygen transmissibility (25 units
difference)
2.62 2.70
(Approximate 95% confidence
interval)
(1.10, 6.23) (1.14, 6.42)
Shown are the log-rank tests of homogeneity of survival curves in the two
oxygen permeability lens groups and the estimated hazard ratios and
approximate 95% confidence intervals derived from Cox proportional
hazards models.
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medium-Dk group experienced more than three times the risk of
EW failure than the high-Dk group. Using the mean subject-
specific Dk/t (i.e., taking individual lens thickness into account) as
a continuous predictor of RGPEW failure, we obtained a relative
hazard of 2.62 (1.10, 6.23) for a 25-unit decrease in Dk/t. From
these results, we concluded that hypoxic dose does significantly
affect the probability of successfully maintaining 6-night RGPEW.
It is possible that the decreased probability of successful EW in
the medium-Dk group, despite comparable rates of initial onset of
CLAK in the two groups, is because of the fact that CLAK is more
likely to result in complete discontinuation of EW for the medi-
um-Dk subjects. To test this hypothesis, we examined the duration
of successful EW from the time of initial onset of any CLAK (type
4) to determine whether the probability of continued survival in
EW after experiencing a CLAK was greater in the high-Dk group.
Figure 5 (second panel) depicts the probability of further sur-
vival in EW after experiencing a type 4 CLAK, which is signifi-
cantly greater in the high-Dk group (P 5 0.01). Table 8 (second
column) illustrates this difference by showing that the probability
of survival for more than 9 months after experiencing a CLAK is
approximately 16% greater in the high-Dk group. The relative
hazard estimate (Table 8, second column) shows that the medi-
um-Dk group experienced more than three times the risk of failing
in EW after first experiencing a CLAK. These results support the
hypothesis that the decreased survival probability among medi-
um-Dk wearers, when risk of CLAK onset appears to be compa-
rable, may be the result of a hypoxic effect on recovery from
CLAK after it develops.
Conclusions
Our primary objectives were to determine whether substan-
tially reducing corneal hypoxia during RGPEW lowers the
incidence of CLAK, failure to maintain EW for 12 months,
or both. Our results suggest that increasing the level of
oxygen available to the cornea during RGPEW significantly
increases the chances of maintaining successful extended
contact lens wear for 12 months. Our best estimate of the
increased risk of failure with the lower oxygen lenses is
approximately threefold; the upper confidence bound sug-
gests that this could be as large as eightfold. However, our
results also suggest that the probability of CLAK develop-
ing is not significantly greater with the lower oxygen lenses.
These results at first seem paradoxical: why would there be
a dramatic elevation in the risk of failure in the medium-DK
group if both groups demonstrate comparable initial CLAK
rates?
One possible explanation is that subjects in the medi-
um-Dk group in whom CLAK did develop were less likely
to recover. The analysis of EW survival rate among those
subjects who experienced CLAK supports this hypothesis,
showing that recovery from CLAK and continued success-
ful RGPEW is less likely under the greater hypoxic dose. It
is possible that the greater dose of hypoxia induced by the
medium-Dk lenses limited the successful resumption of EW
after recovery from an adverse response. Consistent with
this possibility is the observation that five subjects who
were randomized to the medium-Dk lenses (after success-
fully adapting to EW with the high-Dk adaptation lenses)
began to experience recurring, persistent lens adherence that
eventually required discontinuation of EW, whereas only
one of the five high-Dk subjects who experienced adherence
was unable to continue EW after intervention. Is it possible
that hypoxia may in some way be linked to lens adherence?
This speculation requires further investigation.
It is also possible that although the two Dk groups
exhibited similar overall numbers of initial CLAK events,
these events were more severe, on average, in the medi-
um-Dk group, or tended to recur more often after resump-
tion of EW. We determined from a post hoc examination of
the CLEWS data that the severity of responses categorized
as CLAK did not differ between groups; however, we
cannot establish whether CLAK recurred more often under
the lower oxygen condition from the CLEWS data, for
several reasons discussed in detail above.
A third possible explanation for these results is that our
definitions of CLAK did not distinguish between types of
keratopathy that could be more or less resistant to treatment
and eventually require complete discontinuation of EW.
Although far from conclusive, the observation of infiltrates
and striae in the medium-Dk group, which were mostly
absent in the high-Dk group, are consistent with this possi-
bility.
In summary, we suggest that the most likely explanation
for the differences in survival rates between our two study
groups is that the medium-Dk group experienced more of
the types of keratopathies that are most difficult to reverse
(e.g., lens adherence, persistent corneal staining, infiltrates)
and that, after intervention, successful return to EW was less
likely for the medium-Dk group because of the continued
hypoxic exposure. Whatever the exact explanation for the
differences in overall EW success, the clinical implication is
clear: Although Food and Drug Administration-approved
RGPEW lenses are available in a wide range of Dk (40–
92 3 10211 (cm2/second)(ml 02/ml 3 mmHg)), the clini-
cian should prescribe the highest oxygen permeable lens
available to increase the probability for success. As a cau-
tion, we note that these data include only a 1-year period of
observation of subjects recruited from the University of
California Berkeley campus and surrounding community
and enrolled based on CLEWS eligibility criteria. Thus,
generalizing these findings to longer periods of wearing
time or to materially different populations requires further
study.
Table 8. Estimated Probabilities (%) of Survival in Extended
Wear beyond 9 Months for All Subjects, and Survival for More
Than 9 Months after Initial Onset for Those Who Experienced
a Contact Lens-associated Keratopathy Event (Type 4)
All
Subjects
Subjects with
Any Contact
Lens-associated
Keratopathy
(Type 4)
Medium oxygen permeability 82.5 77.7
(74.7, 90.3) (67.4, 87.9)
High oxygen permeability 95.2 94.1
(90.6, 99.8) (88.4, 99.7)
Approximate 95% confidence bounds are included in parentheses.
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The clinical outcomes we have observed in CLEWS
provide some interesting and possibly important informa-
tion about complications accompanying SCLEW. Our find-
ings are in agreement with other clinical studies on RG-
PEW, which show lower incidence and severity of contact
lens-associated complications compared with SCLEW,
even though the oxygen transmissibility of the medium-Dk
lenses in CLEWS is comparable with that of disposable
SCLEW lenses.8–10 A comparison of CLEWS outcomes
with historical results from SCLEW indicates that, com-
pared with RGPEW, SCLEW appears to place the patient at
considerably higher risk for serious and vision-threatening
ocular morbidity. For example, a recent study on disposable
SCLEW reported that over a 13-month follow-up period,
among 100 patients there were 44 cases of infiltrative ker-
atitis that were associated with acute red eye, peripheral
corneal ulcers, keratoconjunctivitis, and other types of oc-
ular morbidity.7 In contrast, of the 201 subjects in CLEWS,
there were only 3 cases of infiltrates and no acute red eyes
or infections.
How can we explain these large differences in compli-
cations between RGPEW and SCLEW when the cornea is
exposed to approximately the same oxygen levels? Perhaps
the answer is related to differences in lens performance and
not hypoxia alone. For example, when the eyes are closed,
there is no tear exchange and debris builds up between the
cornea and lens for both rigid and soft lenses. However, as
soon as the eyes are open, the trapped debris under the rigid
lens is removed within a few blinks because of the good tear
exchange; unfortunately, this is not the case for soft lenses,
which have very poor tear mixing.11 We propose that in
SCLEW, epithelial integrity may be affected because of the
persistence of trapped debris. This hypothesis is consistent
with recent studies showing that closed-eye soft lens wear
can result in a substantial increase in the permeability of the
epithelium to fluorescein.12,13
In summary, although overnight contact lens wear should
be recommended with caution and carefully monitored for
early detection of ocular complications, it appears that
high-Dk RGP lenses can be a relatively safe and effective
treatment for RE. The overall RGP success rate among
subjects who already adapted to overnight wear (approxi-
mately 62%) was reasonably good considering the burdens
of study participation and the lack of any monetary invest-
ment on the part of the patients, and most of those not
completing 1 year of EW exited the study for reasons
unrelated to lens wear (e.g., unwillingness to continue the
time commitment required by the study). However, we note
a substantial drop-out rate from the beginning of the fitting
process to successful EW adaptation (545 subjects fit, 201
successfully adapted to EW). Failure to adapt to EW for
reasons unrelated to the study protocol seems more often to
be the result of discomfort (approximately 34%) than of
serious corneal responses to overnight lens wear (approxi-
mately 17%). This suggests that if improved fitting strate-
gies of rigid materials could be developed to provide im-
proved comfort, RGPEW of high-Dk materials may be a
viable treatment for patients who desire EW.
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